Chlorhexidine Gluconate (CHG) Wipes Market

By Type;

Chlorhexidine Gluconate (CHG) Bath Wipes and Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes

By Application;

Surgical Site Infections, Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, and Others

By Distribution Channel;

Pharmacies, Supermarkets, Specialty Stores, and Direct Sales

By End User;

Hospitals, Clinics, Ambulatory Surgical Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn114105841 Published Date: August, 2025

Chlorhexidine Gluconate (CHG) Wipes Market Overview

Chlorhexidine Gluconate (CHG) Wipes Market (USD Million)

Chlorhexidine Gluconate (CHG) Wipes Market was valued at USD 14,562.64 million in the year 2024. The size of this market is expected to increase to USD 19,685.37 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.


Chlorhexidine Gluconate (CHG) Wipes Market

*Market size in USD million

CAGR 4.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.4 %
Market Size (2024)USD 14,562.64 Million
Market Size (2031)USD 19,685.37 Million
Market ConcentrationHigh
Report Pages377
14,562.64
2024
19,685.37
2031

Major Players

  • Becton Dickinson and Company
  • 3M
  • Cardinal Health
  • GAMA Healthcare Ltd
  • Carenow Medical Pvt. Ltd.
  • PDI Limited
  • Lernapharm Inc.
  • Pal International

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Chlorhexidine Gluconate (CHG) Wipes Market

Fragmented - Highly competitive market without dominant players


The Chlorhexidine Gluconate (CHG) Wipes Market is expanding rapidly as infection control and hygiene become top priorities in healthcare systems. More than 60% of hospitals rely on CHG wipes for reducing healthcare-associated infections, reinforcing their critical role in patient safety protocols. The simple yet effective design of CHG wipes continues to boost their demand across clinical practices.

Rising Usage in Surgical Preparation
One of the strongest growth drivers is the increasing application of CHG wipes in preoperative skin preparation. Currently, around 45% of surgical procedures use these wipes to minimize infection risks, making them a preferred alternative to conventional antiseptics. Their quick application and reliable performance enhance their acceptance among medical professionals.

Growing Adoption Across Care Environments
The usage of CHG wipes extends beyond hospitals into ambulatory centers and home healthcare. Over 35% of patients receiving home treatment now use antiseptic wipes for infection prevention. This trend reflects how infection awareness and convenience are shaping consumer preferences outside of hospital settings.

Innovation Strengthening Market Growth
Advancements in formulation technology are improving both the efficacy and skin tolerance of CHG wipes. Nearly 50% of newly launched products feature dual formulations, combining CHG with alcohol for stronger antimicrobial action. These innovations are creating competitive differentiation and expanding clinical adoption.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Chlorhexidine Gluconate (CHG) Wipes Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Awareness of Antimicrobial Resistance

        2. Surge in Surgical Procedures

        3. Increasing Emphasis on Infection Prevention

      2. Restraints
        1. Potential Side Effects

        2. Cost Considerations

        3. Limited Awareness and Education

      3. Opportunities
        1. Expansion of Healthcare Infrastructure

        2. Expansion into Non-Healthcare Sectors

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Chlorhexidine Gluconate (CHG) Wipes Market, By Type, 2021 - 2031 (USD Million)
      1. Chlorhexidine Gluconate (CHG) Bath Wipes
      2. Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes
    2. Chlorhexidine Gluconate (CHG) Wipes Market, By Application, 2021 - 2031 (USD Million)
      1. Surgical Site Infections
      2. Central Line-Associated Bloodstream Infections
      3. Catheter-Associated Urinary Tract Infections
      4. Others
    3. Chlorhexidine Gluconate (CHG) Wipes Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Pharmacies
      2. Supermarkets
      3. Specialty Stores
      4. Direct Sales
    4. Chlorhexidine Gluconate (CHG) Wipes Market, By End User, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Clinics

      3. Ambulatory Surgical Centers

      4. Others

    5. Chlorhexidine Gluconate (CHG) Wipes Market, By Geography, 2021 - 2031 (USD Million)
      1. North America

        1. United States

        2. Canada

      2. Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Nordic

        7. Benelux

        8. Rest of Europe

      3. Asia Pacific

        1. Japan

        2. China

        3. India

        4. Australia & New Zealand

        5. South Korea

        6. ASEAN (Association of South East Asian Countries)

        7. Rest of Asia Pacific

      4. Middle East & Africa

        1. GCC

        2. Israel

        3. South Africa

        4. Rest of Middle East & Africa

      5. Latin America

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

  6. Competitive Landscape
    1. Company Profiles
      1. Becton Dickinson and Company

      2. 3M

      3. Cardinal Health

      4. GAMA Healthcare Ltd

      5. Carenow Medical Pvt. Ltd.

      6. PDI Limited

      7. Lernapharm Inc.

      8. Pal International

  7. Analyst Views
  8. Future Outlook of the Market